Sign in with Google
bearish
Celltrion/Celltrion H Pair: Last 2 Days Must Be Price Divergence, Not Mean Reversion
813 Views29 Dec 2018 17:35
The accounting fraud issue had hammered the Celltrion duo nearly equally up until Dec 26. But last two days were different. Healthcare got hurt...
SUMMARY
(Sign Up to Access)Full Insight
(Paid Plans Only, 3-minute read)
Related Insights
More »Loading
Trending Collections
More »Trending Insights
More »- Japan Weekly | Geopolitics Rule as Semis Shine and Autos Stumble
- Taiwan Top 50 ETF Rebalance: Elite Materials Added (But Bigger Sell Flows Elsewhere)
- Last Week in Event SPACE: Toyota Indust. Great Eastern, Mayne Pharma, Shibaura Elect., New World
- India's Unexpected 0.5% Rate Cut: Friday’s Market Reaction Breakdown
- HEW: Poorly Positioned Doves
Top Unpaywalled Insights
More »- [IO Technicals 2025/23] Bearish Momentum Persists
- VEON US: Pakistan Towers Sale Frees Capital for Digital Growth in Core Market Ahead of Ukraine IPO
- Advanced Look: Navigating the New Macro Landscape Through Quantitative Alpha Generation Strategies
- [IO Technicals 2025/22] Bearish Momentum Strengthens
- Texas Power Play: Grid Sovereignty, Bitcoin, and the Future of AI
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Celltrion Bullish off of Cycle Low with Base Risk Tactics20 Jun 2019
- Celltrion H Block Deals Priced at Floor: More Short Entry Points Should Be On the Way21 May 2019
- Celltrion Cycle Low Synergies30 Apr 2019
- Celltrion / Celltrion Healthcare Pair Trade: Ratio Should Move in Favor of Healthcare13 Dec 2018
- Celltrion Placement Is Prelude to Merger: Initiate Pair Trade (Short Celltrion/Long Healthcare)22 Oct 2018
x